Ask a question. Get a source-grounded answer with citations.
Based on 10 verified sources covering Thailand, Myanmar:
A 27-year-old veterinary officer under training died after she suffered serious injuries following an attack by a hippopotamus at Tyavarekoppa Lion and Tiger Safari in Shivamogga. Dr. [1]
MUMBAI (NewsRise) -- A U.S. federal court has found that Dr. Reddy's Laboratories' generic formulation of anti-nausea injection drug Aloxi infringes certain patents, blocking its launch in the largest pharmaceutical market in the world. BusinessU.S. [2]
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories reported a better-than-expected 45% jump in first-quarter net profit as the Indian drugmaker gained from a settlement agreement in the U.S. PharmaceuticalsDr. (confirmed by 2 sources) [3]
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest pharmaceutical company, warned of a bleak outlook amid delayed approvals for key products in the U.S., after reporting a better-than-expected quarterly profit aided by tighter cost... [4]
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories said first-quarter net income slumped 57% from a year earlier, as rising pricing pressure in the U.S. [5]
MUMBAI (NewsRise) -- The U.S. drug regulator has raised more concerns about the manufacturing practices at India's Dr. [6]
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories got a breather after a court allowed it to sell a generic version of Indivior's drug addiction treatment Suboxone Film in the U.S., where the Indian company is short on new launches. CompaniesDr. [7]
MUMBAI (NewsRise) -- Indian drugmaker Dr. Reddy's Laboratories reported a surprise loss in the third quarter, hurt by an impairment charge related to the launch of a new generic drug and related products. PharmaceuticalsDr. [8]
A 27-year-old veterinary officer under training died after she suffered serious injuries following an attack by a hippopotamus at Tyavarekoppa Lion and Tiger Safari in Shivamogga. Dr.
MUMBAI (NewsRise) -- A U.S. federal court has found that Dr. Reddy's Laboratories' generic formulation of anti-nausea injection drug Aloxi infringes certain patents, blocking its launch in the largest pharmaceutical market in the world. BusinessU.S.
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories reported a better-than-expected 45% jump in first-quarter net profit as the Indian drugmaker gained from a settlement agreement in the U.S. PharmaceuticalsDr.
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest pharmaceutical company, warned of a bleak outlook amid delayed approvals for key products in the U.S., after reporting a better-than-expected quarterly profit aided by tighter cost
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories said first-quarter net income slumped 57% from a year earlier, as rising pricing pressure in the U.S.
MUMBAI (NewsRise) -- The U.S. drug regulator has raised more concerns about the manufacturing practices at India's Dr.
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories got a breather after a court allowed it to sell a generic version of Indivior's drug addiction treatment Suboxone Film in the U.S., where the Indian company is short on new launches. CompaniesDr.
MUMBAI (NewsRise) -- Indian drugmaker Dr. Reddy's Laboratories reported a surprise loss in the third quarter, hurt by an impairment charge related to the launch of a new generic drug and related products. PharmaceuticalsDr.
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories reported a better-than-expected 65% surge in third-quarter net profit, as the Indian drug maker gained from the sale of a unit and lower taxes. CompaniesDr.
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest drug maker, reported a better-than-expected second-quarter net income on Tuesday, as improved efficiency in its operations helped tide over rising pricing pressure in the U.S.